Clearmind Gains IRB Approval At TASMC For Alcohol Use Disorder Drug Trial July 03, 2025 — 01:23 pm EDT Written by RTTNews.com for RTTNews -> ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...

A new clinical trial using a botanical psilocybin drug to treat co-occurring PTSD and alcohol use disorder (AUD) in veterans ...

Clearmind Medicine gets IRB nod from TASMC for phase 1/2a clinical trial to evaluate CMND-100 for treatment of alcohol use disorder: Vancouver, Canada Saturday, July 5, 2025, 18:0 ...

Cuyahoga County will use $7 million from opioid settlements to build a "first-of-its-kind" behavioral health crisis center ...

The Drugs Consultative Committee (DCC) has agreed to amend the Drugs Rules, 1945 to regulate the alcohol content in tinctures ...

Generic Ablysinol is indicated for the induction of controlled cardiac septal infarction to improve exercise capacity in adult patients with hypertrophic obstructive cardiomyopathy.

Aldeyra's Reproxalap progresses towards FDA approval, with a potential $100M AbbVie deal. There’s still upside potential, ...

A new care center for homeless people on Los Angeles' infamous Skid Row embraces the principle of harm reduction, a more ...

Does using Ozempic cause brain fog? It depends on who you ask. This article takes a closer look at what’s going on with ...

A motorcyclist was fatally struck by a car on Airline Drive, and now the driver has been arrested for possible impairment.

Atai Life Sciences is making incremental progress towards opening door for a first psychedelic treatment for depression. Read ...